Cornerstone Capital Management Holdings’s Precigen PGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q2
Sell
-7,679
Closed -$258K 1468
2016
Q1
$258K Sell
7,679
-11,450
-60% -$360K ﹤0.01% 1170
2015
Q4
$571K Sell
19,129
-13,530
-41% -$456K ﹤0.01% 1011
2015
Q3
$1.03M Buy
32,659
+9,249
+40% +$451K 0.01% 874
2015
Q2
$1.13M Buy
23,410
+20,480
+699% +$863K 0.01% 846
2015
Q1
$127K Buy
+2,930
New +$105K ﹤0.01% 1238

Other funds holding PGEN

Cornerstone Capital Management Holdings's PGEN Position: Q2 2016 in Review

Cornerstone Capital Management Holdings sold out of Precigen (PGEN) in Q2 2016, closing a stake of 7,679 shares — an estimated $258K sold.

Cornerstone Capital Management Holdings first reported a position in PGEN in Q1 2015 and held it in 5 quarters. The position peaked at $1.13M in Q2 2015. 169 funds tracked by Wall St. Rank hold PGEN as of Q2 2016.

  • Cornerstone Capital Management Holdings reported no remaining Precigen position as of Q2 2016 after selling out during the quarter.
  • Cornerstone Capital Management Holdings sold 7,679 Precigen shares in Q2 2016, an estimated $258K.
  • Cornerstone Capital Management Holdings first reported a position in Precigen in Q1 2015 and held it in 5 quarters.
  • Cornerstone Capital Management Holdings's Precigen position peaked at $1.13M in Q2 2015.
  • 169 funds tracked by Wall St. Rank held Precigen as of Q2 2016.

Based on Cornerstone Capital Management Holdings's 13F filing for Q2 2016, filed 12 Aug 2016.